Ipamorelin
Selective growth-hormone secretagogue. Initial characterisation in animal models in 1998.[1]
PayPal or cash on collection · UK 18+ verification at checkout · For laboratory research use only
Certificate of analysis
The certificate we hold
These reports were commissioned by the manufacturer who supplies our raw material, not by Optimal Lab, and they test that raw material rather than a finished vial. They state how much compound was measured and its purity by HPLC — they do not test identity.
- 10mg99.736% purity24 JUN 2026Janoshik Analytical s.r.o.View certificate
Selected research · Ipamorelin
- [1]Characterisation of Ipamorelin as a selective GH secretagogue without cortisol or prolactin elevation in animal models.Raun K, Hansen BS, Johansen NL, et al. (1998). Ipamorelin, the first selective growth hormone secretagogue. European Journal of Endocrinology.PMID 9849822 →
All references describe published research on the compound. They do not constitute clinical guidance or imply therapeutic benefit to any individual purchaser. For laboratory research use only.
Frequently bought together
Full catalogue →Retatrutide
Triple agonist (GLP-1/GIP/glucagon receptor). Studied in preclinical metabolic research.
From £60.00
CJC-1295 (no DAC)
GHRH analogue (Mod GRF 1-29) without DAC. Short-acting growth-hormone-releasing peptide researched in pulsatile GH secretion studies. Commonly paired with Ipamorelin.
From £30.00
GHK-Cu
Copper peptide naturally occurring in plasma. Studied in preclinical research on skin remodelling, wound-repair pathways, and gene-expression modulation. Referenced in cellular-senescence research groupings.
From £30.00
Tesamorelin
GHRH analogue. Studied in clinical research on growth-hormone secretion and visceral-adiposity endpoints.
From £55.00